Breaking News, Collaborations & Alliances

Cobra Biologics Awarded $3.4M by Innovate UK

As part of a strategy boost for UK medicines with £70 million of funding

Cobra Biologics has been awarded £2.6 million ($3.4 million) capital infrastructure investment by Innovate UK.    The award was given under Innovate UK’s Industrial Strategy boost for UK medicines with £70 million of funding to help develop new treatments. The investment will go towards a £5 million development project, which feeds into a £15 million company expansion announced by Cobra in 2017. The expansion will be to advance world leading capabilities for clinical and commercial produ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters